EcoR1 Capital »

Mannkind shares owned by EcoR1 Capital

Quarter-by-quarter ownership of Mannkind (MNKD) shares owned by EcoR1 Capital from 13F filings

Historical chart of EcoR1 Capital investment in Mannkind

Tip: Access up to 7 years of quarterly data

All positions including Mannkind held by EcoR1 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mannkind by EcoR1 Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.4M 1.7M 5.67

More positions owned by EcoR1 Capital

Zymeworks Del (ZYME)
Anaptysbio Inc Common (ANAB)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Crinetics Pharmaceuticals In (CRNX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Crispr Therapeutics Namen Akt (CRSP)
Mbx Biosciences (MBX)
Immunome (IMNM)
Oric Pharmaceuticals (ORIC)
Galapagos Nv Spon Adr (GLPG)
Xencor (XNCR)
Cg Oncology (CGON)
Bridgebio Oncology Therapeut Com New (BBOT)
Eton Pharmaceuticals (ETON)
Zenas Biopharma (ZBIO)

View all positions for EcoR1 Capital

Top funds holding Mannkind

BlackRock
Vanguard Group
State Street Corporation
Rubric Capital Management
Geode Capital Management
Nitorum Capital
UBS Group
venBio Select Advisor
Dimensional Fund Advisors
Frazier Life Sciences Management
Wellington Management Company
FMR
TSP Capital Management Group
180 Wealth Advisors
Northern Trust

View all funds holding Mannkind